101
|
Morra JH, Tu Z, Apostolova LG, Green AE, Avedissian C, Madsen SK, Parikshak N, Toga AW, Jack CR, Schuff N, Weiner MW, Thompson PM. Automated mapping of hippocampal atrophy in 1-year repeat MRI data from 490 subjects with Alzheimer's disease, mild cognitive impairment, and elderly controls. Neuroimage 2009; 45:S3-15. [PMID: 19041724 PMCID: PMC2733354 DOI: 10.1016/j.neuroimage.2008.10.043] [Citation(s) in RCA: 169] [Impact Index Per Article: 10.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/17/2008] [Accepted: 10/10/2008] [Indexed: 11/16/2022] Open
Abstract
As one of the earliest structures to degenerate in Alzheimer's disease (AD), the hippocampus is the target of many studies of factors that influence rates of brain degeneration in the elderly. In one of the largest brain mapping studies to date, we mapped the 3D profile of hippocampal degeneration over time in 490 subjects scanned twice with brain MRI over a 1-year interval (980 scans). We examined baseline and 1-year follow-up scans of 97 AD subjects (49 males/48 females), 148 healthy control subjects (75 males/73 females), and 245 subjects with mild cognitive impairment (MCI; 160 males/85 females). We used our previously validated automated segmentation method, based on AdaBoost, to create 3D hippocampal surface models in all 980 scans. Hippocampal volume loss rates increased with worsening diagnosis (normal=0.66%/year; MCI=3.12%/year; AD=5.59%/year), and correlated with both baseline and interval changes in Mini-Mental State Examination (MMSE) scores and global and sum-of-boxes Clinical Dementia Rating scale (CDR) scores. Surface-based statistical maps visualized a selective profile of ongoing atrophy in all three diagnostic groups. Healthy controls carrying the ApoE4 gene atrophied faster than non-carriers, while more educated controls atrophied more slowly; converters from MCI to AD showed faster atrophy than non-converters. Hippocampal loss rates can be rapidly mapped, and they track cognitive decline closely enough to be used as surrogate markers of Alzheimer's disease in drug trials. They also reveal genetically greater atrophy in cognitively intact subjects.
Collapse
Affiliation(s)
- Jonathan H. Morra
- Laboratory of Neuro Imaging, Dept. of Neurology, UCLA School of Medicine, Neuroscience Research Building 225E, 635 Charles Young Drive, Los Angeles, CA 90095-1769, USA
| | - Zhuowen Tu
- Laboratory of Neuro Imaging, Dept. of Neurology, UCLA School of Medicine, Neuroscience Research Building 225E, 635 Charles Young Drive, Los Angeles, CA 90095-1769, USA
| | - Liana G. Apostolova
- Laboratory of Neuro Imaging, Dept. of Neurology, UCLA School of Medicine, Neuroscience Research Building 225E, 635 Charles Young Drive, Los Angeles, CA 90095-1769, USA
- Dept. of Neurology, UCLA School of Medicine, Los Angeles, CA, USA
| | - Amity E. Green
- Laboratory of Neuro Imaging, Dept. of Neurology, UCLA School of Medicine, Neuroscience Research Building 225E, 635 Charles Young Drive, Los Angeles, CA 90095-1769, USA
- Dept. of Neurology, UCLA School of Medicine, Los Angeles, CA, USA
| | - Christina Avedissian
- Laboratory of Neuro Imaging, Dept. of Neurology, UCLA School of Medicine, Neuroscience Research Building 225E, 635 Charles Young Drive, Los Angeles, CA 90095-1769, USA
| | - Sarah K. Madsen
- Laboratory of Neuro Imaging, Dept. of Neurology, UCLA School of Medicine, Neuroscience Research Building 225E, 635 Charles Young Drive, Los Angeles, CA 90095-1769, USA
| | - Neelroop Parikshak
- Laboratory of Neuro Imaging, Dept. of Neurology, UCLA School of Medicine, Neuroscience Research Building 225E, 635 Charles Young Drive, Los Angeles, CA 90095-1769, USA
| | - Arthur W. Toga
- Laboratory of Neuro Imaging, Dept. of Neurology, UCLA School of Medicine, Neuroscience Research Building 225E, 635 Charles Young Drive, Los Angeles, CA 90095-1769, USA
| | | | - Norbert Schuff
- Department of Veterans Affairs Medical Center, and Dept. Radiology, UC San Francisco, San Francisco, CA, USA
| | - Michael W. Weiner
- Department of Veterans Affairs Medical Center, and Dept. Radiology, UC San Francisco, San Francisco, CA, USA
- Dept. Medicine and Psychiatry, UC San Francisco, San Francisco, CA, USA
| | - Paul M. Thompson
- Laboratory of Neuro Imaging, Dept. of Neurology, UCLA School of Medicine, Neuroscience Research Building 225E, 635 Charles Young Drive, Los Angeles, CA 90095-1769, USA
| |
Collapse
|
102
|
Tsaltas E, Kontis D, Boulougouris V, Papadimitriou GN. Lithium and cognitive enhancement: leave it or take it? Psychopharmacology (Berl) 2009; 202:457-76. [PMID: 18781296 DOI: 10.1007/s00213-008-1311-8] [Citation(s) in RCA: 37] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/28/2008] [Accepted: 08/20/2008] [Indexed: 12/19/2022]
Abstract
RATIONALE Lithium is established as an effective treatment of acute mania, bipolar and unipolar depression and as prophylaxis against bipolar disorder. Accumulating evidence is also delineating a neuroprotective and neurotrophic role for lithium. However, its primary effects on cognitive functioning remain ambiguous. OBJECTIVES The aim of this paper is to review and combine the relevant translational studies, focusing on the putative cognitive enhancement properties of lithium, specifically on learning, memory, and attention. DISCUSSION These properties are also discussed in reference to research demonstrating a protective action of lithium against cognitive deficits induced by various challenges to the nervous system, such as stress, trauma, neurodegenerative disorders, and psychiatric disorders. CONCLUSIONS It is suggested on the basis of the evidence that the cognitive effects of lithium are best expressed and should, therefore, be sought under conditions of functional or biological challenge to the nervous system.
Collapse
Affiliation(s)
- Eleftheria Tsaltas
- Experimental Psychology Laboratory, Department of Psychiatry, Eginition Hospital, Athens University Medical School, 74 Vas. Sofias Avenue, 11528 Athens, Greece.
| | | | | | | |
Collapse
|
104
|
Bearden CE, Soares JC, Klunder AD, Nicoletti M, Dierschke N, Hayashi KM, Narr KL, Brambilla P, Sassi RB, Axelson D, Ryan N, Birmaher B, Thompson PM. Three-dimensional mapping of hippocampal anatomy in adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry 2008; 47:515-525. [PMID: 18356767 PMCID: PMC2773145 DOI: 10.1097/chi.0b013e31816765ab] [Citation(s) in RCA: 46] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/29/2022]
Abstract
OBJECTIVE Early-onset bipolar disorder is thought to be a particularly severe variant of the illness. Continuity with the adult form of illness remains unresolved, but preliminary evidence suggests similar biological underpinnings. Recently, we observed localized hippocampal decreases in unmedicated adults with bipolar disorder that were not detectable with conventional volumetric measures. Using the same three-dimensional mapping methods, we sought to investigate whether a similar pattern exists in adolescents with bipolar disorder. METHOD High-resolution brain magnetic resonance images were acquired from 16 adolescents meeting DSM-IV criteria for bipolar disorder (mean age 15.5 +/- 3.4 years, 50% female) and 20 demographically matched, typically developing control subjects. Three-dimensional parametric mesh models of the hippocampus were created from manual tracings of the hippocampal formation. RESULTS Controlling for total brain volume, total hippocampal volume was significantly smaller in adolescent patients with bipolar disorder relative to controls (by 9.2%). Statistical mapping results, confirmed by permutation testing, revealed significant localized deformations in the head and tail of the left hippocampus in adolescents with bipolar disorder, relative to normal controls. In addition, there was a significant positive correlation between hippocampal size and age in patients with bipolar disorder, whereas healthy controls showed an inverse relation. DISCUSSION Localized hippocampal deficits in adolescent patients with bipolar disorder suggest a possible neural correlate for memory deficits observed in this illness. Moreover, age-related increases in hippocampal size in patients with bipolar disorder, not observed in healthy controls, may reflect abnormal developmental mechanisms in bipolar disorder. This possibility must be confirmed by longitudinal studies.
Collapse
Affiliation(s)
- Carrie E Bearden
- Dr. Bearden is with the Semel Institute for Neuroscience and Human Behavior and Department of Psychology, University of California, Los Angeles; Dr. Soares and Mr. Nicoletti are with the Department of Psychiatry, University of North Carolina at Chapel Hill School of Medicine; Ms. Klunder, Ms. Hayashi, and Drs. Narr and Thompson are with the Laboratory of NeuroImaging, UCLA School of Medicine; Ms. Dierschke is with the Department of Psychiatry, University of Texas Health Science Center at San Antonio; Dr. Brambilla is with the Scientific Institute IRCCS; Dr. Sassi is with the Department of Psychiatry, University of Sao Paulo School of Medicine; Drs. Axelson, Ryan, and Birmaher are with the Department of Psychiatry, University of Pittsburgh School of Medicine..
| | - Jair C Soares
- Dr. Bearden is with the Semel Institute for Neuroscience and Human Behavior and Department of Psychology, University of California, Los Angeles; Dr. Soares and Mr. Nicoletti are with the Department of Psychiatry, University of North Carolina at Chapel Hill School of Medicine; Ms. Klunder, Ms. Hayashi, and Drs. Narr and Thompson are with the Laboratory of NeuroImaging, UCLA School of Medicine; Ms. Dierschke is with the Department of Psychiatry, University of Texas Health Science Center at San Antonio; Dr. Brambilla is with the Scientific Institute IRCCS; Dr. Sassi is with the Department of Psychiatry, University of Sao Paulo School of Medicine; Drs. Axelson, Ryan, and Birmaher are with the Department of Psychiatry, University of Pittsburgh School of Medicine
| | - Andrea D Klunder
- Dr. Bearden is with the Semel Institute for Neuroscience and Human Behavior and Department of Psychology, University of California, Los Angeles; Dr. Soares and Mr. Nicoletti are with the Department of Psychiatry, University of North Carolina at Chapel Hill School of Medicine; Ms. Klunder, Ms. Hayashi, and Drs. Narr and Thompson are with the Laboratory of NeuroImaging, UCLA School of Medicine; Ms. Dierschke is with the Department of Psychiatry, University of Texas Health Science Center at San Antonio; Dr. Brambilla is with the Scientific Institute IRCCS; Dr. Sassi is with the Department of Psychiatry, University of Sao Paulo School of Medicine; Drs. Axelson, Ryan, and Birmaher are with the Department of Psychiatry, University of Pittsburgh School of Medicine
| | - Mark Nicoletti
- Dr. Bearden is with the Semel Institute for Neuroscience and Human Behavior and Department of Psychology, University of California, Los Angeles; Dr. Soares and Mr. Nicoletti are with the Department of Psychiatry, University of North Carolina at Chapel Hill School of Medicine; Ms. Klunder, Ms. Hayashi, and Drs. Narr and Thompson are with the Laboratory of NeuroImaging, UCLA School of Medicine; Ms. Dierschke is with the Department of Psychiatry, University of Texas Health Science Center at San Antonio; Dr. Brambilla is with the Scientific Institute IRCCS; Dr. Sassi is with the Department of Psychiatry, University of Sao Paulo School of Medicine; Drs. Axelson, Ryan, and Birmaher are with the Department of Psychiatry, University of Pittsburgh School of Medicine
| | - Nicole Dierschke
- Dr. Bearden is with the Semel Institute for Neuroscience and Human Behavior and Department of Psychology, University of California, Los Angeles; Dr. Soares and Mr. Nicoletti are with the Department of Psychiatry, University of North Carolina at Chapel Hill School of Medicine; Ms. Klunder, Ms. Hayashi, and Drs. Narr and Thompson are with the Laboratory of NeuroImaging, UCLA School of Medicine; Ms. Dierschke is with the Department of Psychiatry, University of Texas Health Science Center at San Antonio; Dr. Brambilla is with the Scientific Institute IRCCS; Dr. Sassi is with the Department of Psychiatry, University of Sao Paulo School of Medicine; Drs. Axelson, Ryan, and Birmaher are with the Department of Psychiatry, University of Pittsburgh School of Medicine
| | - Kiralee M Hayashi
- Dr. Bearden is with the Semel Institute for Neuroscience and Human Behavior and Department of Psychology, University of California, Los Angeles; Dr. Soares and Mr. Nicoletti are with the Department of Psychiatry, University of North Carolina at Chapel Hill School of Medicine; Ms. Klunder, Ms. Hayashi, and Drs. Narr and Thompson are with the Laboratory of NeuroImaging, UCLA School of Medicine; Ms. Dierschke is with the Department of Psychiatry, University of Texas Health Science Center at San Antonio; Dr. Brambilla is with the Scientific Institute IRCCS; Dr. Sassi is with the Department of Psychiatry, University of Sao Paulo School of Medicine; Drs. Axelson, Ryan, and Birmaher are with the Department of Psychiatry, University of Pittsburgh School of Medicine
| | - Katherine L Narr
- Dr. Bearden is with the Semel Institute for Neuroscience and Human Behavior and Department of Psychology, University of California, Los Angeles; Dr. Soares and Mr. Nicoletti are with the Department of Psychiatry, University of North Carolina at Chapel Hill School of Medicine; Ms. Klunder, Ms. Hayashi, and Drs. Narr and Thompson are with the Laboratory of NeuroImaging, UCLA School of Medicine; Ms. Dierschke is with the Department of Psychiatry, University of Texas Health Science Center at San Antonio; Dr. Brambilla is with the Scientific Institute IRCCS; Dr. Sassi is with the Department of Psychiatry, University of Sao Paulo School of Medicine; Drs. Axelson, Ryan, and Birmaher are with the Department of Psychiatry, University of Pittsburgh School of Medicine
| | - Paolo Brambilla
- Dr. Bearden is with the Semel Institute for Neuroscience and Human Behavior and Department of Psychology, University of California, Los Angeles; Dr. Soares and Mr. Nicoletti are with the Department of Psychiatry, University of North Carolina at Chapel Hill School of Medicine; Ms. Klunder, Ms. Hayashi, and Drs. Narr and Thompson are with the Laboratory of NeuroImaging, UCLA School of Medicine; Ms. Dierschke is with the Department of Psychiatry, University of Texas Health Science Center at San Antonio; Dr. Brambilla is with the Scientific Institute IRCCS; Dr. Sassi is with the Department of Psychiatry, University of Sao Paulo School of Medicine; Drs. Axelson, Ryan, and Birmaher are with the Department of Psychiatry, University of Pittsburgh School of Medicine
| | - Roberto B Sassi
- Dr. Bearden is with the Semel Institute for Neuroscience and Human Behavior and Department of Psychology, University of California, Los Angeles; Dr. Soares and Mr. Nicoletti are with the Department of Psychiatry, University of North Carolina at Chapel Hill School of Medicine; Ms. Klunder, Ms. Hayashi, and Drs. Narr and Thompson are with the Laboratory of NeuroImaging, UCLA School of Medicine; Ms. Dierschke is with the Department of Psychiatry, University of Texas Health Science Center at San Antonio; Dr. Brambilla is with the Scientific Institute IRCCS; Dr. Sassi is with the Department of Psychiatry, University of Sao Paulo School of Medicine; Drs. Axelson, Ryan, and Birmaher are with the Department of Psychiatry, University of Pittsburgh School of Medicine
| | - David Axelson
- Dr. Bearden is with the Semel Institute for Neuroscience and Human Behavior and Department of Psychology, University of California, Los Angeles; Dr. Soares and Mr. Nicoletti are with the Department of Psychiatry, University of North Carolina at Chapel Hill School of Medicine; Ms. Klunder, Ms. Hayashi, and Drs. Narr and Thompson are with the Laboratory of NeuroImaging, UCLA School of Medicine; Ms. Dierschke is with the Department of Psychiatry, University of Texas Health Science Center at San Antonio; Dr. Brambilla is with the Scientific Institute IRCCS; Dr. Sassi is with the Department of Psychiatry, University of Sao Paulo School of Medicine; Drs. Axelson, Ryan, and Birmaher are with the Department of Psychiatry, University of Pittsburgh School of Medicine
| | - Neal Ryan
- Dr. Bearden is with the Semel Institute for Neuroscience and Human Behavior and Department of Psychology, University of California, Los Angeles; Dr. Soares and Mr. Nicoletti are with the Department of Psychiatry, University of North Carolina at Chapel Hill School of Medicine; Ms. Klunder, Ms. Hayashi, and Drs. Narr and Thompson are with the Laboratory of NeuroImaging, UCLA School of Medicine; Ms. Dierschke is with the Department of Psychiatry, University of Texas Health Science Center at San Antonio; Dr. Brambilla is with the Scientific Institute IRCCS; Dr. Sassi is with the Department of Psychiatry, University of Sao Paulo School of Medicine; Drs. Axelson, Ryan, and Birmaher are with the Department of Psychiatry, University of Pittsburgh School of Medicine
| | - Boris Birmaher
- Dr. Bearden is with the Semel Institute for Neuroscience and Human Behavior and Department of Psychology, University of California, Los Angeles; Dr. Soares and Mr. Nicoletti are with the Department of Psychiatry, University of North Carolina at Chapel Hill School of Medicine; Ms. Klunder, Ms. Hayashi, and Drs. Narr and Thompson are with the Laboratory of NeuroImaging, UCLA School of Medicine; Ms. Dierschke is with the Department of Psychiatry, University of Texas Health Science Center at San Antonio; Dr. Brambilla is with the Scientific Institute IRCCS; Dr. Sassi is with the Department of Psychiatry, University of Sao Paulo School of Medicine; Drs. Axelson, Ryan, and Birmaher are with the Department of Psychiatry, University of Pittsburgh School of Medicine
| | - Paul M Thompson
- Dr. Bearden is with the Semel Institute for Neuroscience and Human Behavior and Department of Psychology, University of California, Los Angeles; Dr. Soares and Mr. Nicoletti are with the Department of Psychiatry, University of North Carolina at Chapel Hill School of Medicine; Ms. Klunder, Ms. Hayashi, and Drs. Narr and Thompson are with the Laboratory of NeuroImaging, UCLA School of Medicine; Ms. Dierschke is with the Department of Psychiatry, University of Texas Health Science Center at San Antonio; Dr. Brambilla is with the Scientific Institute IRCCS; Dr. Sassi is with the Department of Psychiatry, University of Sao Paulo School of Medicine; Drs. Axelson, Ryan, and Birmaher are with the Department of Psychiatry, University of Pittsburgh School of Medicine
| |
Collapse
|